Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 0 | 2,135 | 3,004 |
| Cost of Goods | N/A | N/A | N/A | 620 | 608 |
| Gross Profit | N/A | N/A | N/A | 1,515 | 2,396 |
| Operating Expenses | -16,551 | 5,676 | 7,181 | 31,801 | 35,611 |
| Operating Income | 14,416 | -5,676 | -7,181 | -29,666 | -32,607 |
| Other Income | -629 | 163 | 206 | -1,030 | 270 |
| Pre-tax Income | 13,787 | -5,513 | -6,975 | -30,696 | -32,337 |
| Net Income Continuous | 13,787 | -5,513 | -6,975 | -30,696 | -32,337 |
| Net Income | $13,787 | $-5,513 | $-6,975 | $-30,696 | $-32,337 |
| EPS Basic Total Ops | 13.67 | -2.14 | -2.71 | -20.24 | -21.52 |
| EPS Basic Continuous Ops | 13.67 | -2.14 | -2.71 | -20.24 | -21.37 |
| EPS Diluted Total Ops | 13.67 | -2.14 | -2.71 | -20.24 | -21.52 |
| EPS Diluted Continuous Ops | 13.67 | -2.14 | -2.71 | -20.24 | -21.37 |
| EPS Diluted Before Non-Recurring Items | N/A | -5.40 | -13.33 | N/A | N/A |
| EBITDA(a) | $16,575 | $-5,652 | $-7,176 | $-29,624 | $-31,912 |